Test of Known-Groups Validity, as Assessed by FLU-PRO Plus, Comparing FLU-PRO Plus Domain and Total Scores With 3 Categories of Severity on the Patient Global Assessment of Influenza-like Illness Scale, Using Analysis of Variance and Pairwise t Tests
Scale . | Patient Global Assessment of ILI Severity . | F Value . | ||
---|---|---|---|---|
No/Mild . | Moderate . | Severe/Very Severe . | ||
(n=148) . | (n=63) . | (n=15) . | ||
Nose | 1.0 (0.8)a,b | 1.5 (1.0)a | 1.8 (1.2)b | 10.5 |
Throat | 0.4 (0.7)a,b | 1.2 (1.0)a | 1.4 (0.9)b | 24.7 |
Eyes | 0.3 (0.6)a,b | 0.9 (1.0)a,c | 1.6 (1.1)b,c | 26.4 |
Systemic | 0.8 (0.7)a,b | 1.8 (0.8)a,c | 2.5 (0.8)b,c | 62.9 |
Respiratory | 0.6 (0.5)a,b | 1.3 (0.6)a,c | 1.7 (0.6)b,c | 47.7 |
GI | 0.4 (0.4)a,b | 0.8 (0.6)a,c | 1.3 (0.9)b,c | 32.7 |
Senses | 1.2 (1.5)a,b | 1.9 (1.6)a | 2.2 (1.6)b | 5.6 |
Total (not including senses) | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.6)b,c | 74.4 |
Total | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.5)b,c | 64.1 |
Scale . | Patient Global Assessment of ILI Severity . | F Value . | ||
---|---|---|---|---|
No/Mild . | Moderate . | Severe/Very Severe . | ||
(n=148) . | (n=63) . | (n=15) . | ||
Nose | 1.0 (0.8)a,b | 1.5 (1.0)a | 1.8 (1.2)b | 10.5 |
Throat | 0.4 (0.7)a,b | 1.2 (1.0)a | 1.4 (0.9)b | 24.7 |
Eyes | 0.3 (0.6)a,b | 0.9 (1.0)a,c | 1.6 (1.1)b,c | 26.4 |
Systemic | 0.8 (0.7)a,b | 1.8 (0.8)a,c | 2.5 (0.8)b,c | 62.9 |
Respiratory | 0.6 (0.5)a,b | 1.3 (0.6)a,c | 1.7 (0.6)b,c | 47.7 |
GI | 0.4 (0.4)a,b | 0.8 (0.6)a,c | 1.3 (0.9)b,c | 32.7 |
Senses | 1.2 (1.5)a,b | 1.9 (1.6)a | 2.2 (1.6)b | 5.6 |
Total (not including senses) | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.6)b,c | 74.4 |
Total | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.5)b,c | 64.1 |
Data are presented as mean (standard deviation) unless otherwise indicated.
Abbreviations: GI, gastrointestinal; ILI, influenza-like illness.
No/mild symptoms compared with moderate symptoms (P<.05).
No/mild symptoms compared with severe symptoms (P<.05).
Moderate symptoms compared with severe symptoms (P<.05).
Test of Known-Groups Validity, as Assessed by FLU-PRO Plus, Comparing FLU-PRO Plus Domain and Total Scores With 3 Categories of Severity on the Patient Global Assessment of Influenza-like Illness Scale, Using Analysis of Variance and Pairwise t Tests
Scale . | Patient Global Assessment of ILI Severity . | F Value . | ||
---|---|---|---|---|
No/Mild . | Moderate . | Severe/Very Severe . | ||
(n=148) . | (n=63) . | (n=15) . | ||
Nose | 1.0 (0.8)a,b | 1.5 (1.0)a | 1.8 (1.2)b | 10.5 |
Throat | 0.4 (0.7)a,b | 1.2 (1.0)a | 1.4 (0.9)b | 24.7 |
Eyes | 0.3 (0.6)a,b | 0.9 (1.0)a,c | 1.6 (1.1)b,c | 26.4 |
Systemic | 0.8 (0.7)a,b | 1.8 (0.8)a,c | 2.5 (0.8)b,c | 62.9 |
Respiratory | 0.6 (0.5)a,b | 1.3 (0.6)a,c | 1.7 (0.6)b,c | 47.7 |
GI | 0.4 (0.4)a,b | 0.8 (0.6)a,c | 1.3 (0.9)b,c | 32.7 |
Senses | 1.2 (1.5)a,b | 1.9 (1.6)a | 2.2 (1.6)b | 5.6 |
Total (not including senses) | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.6)b,c | 74.4 |
Total | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.5)b,c | 64.1 |
Scale . | Patient Global Assessment of ILI Severity . | F Value . | ||
---|---|---|---|---|
No/Mild . | Moderate . | Severe/Very Severe . | ||
(n=148) . | (n=63) . | (n=15) . | ||
Nose | 1.0 (0.8)a,b | 1.5 (1.0)a | 1.8 (1.2)b | 10.5 |
Throat | 0.4 (0.7)a,b | 1.2 (1.0)a | 1.4 (0.9)b | 24.7 |
Eyes | 0.3 (0.6)a,b | 0.9 (1.0)a,c | 1.6 (1.1)b,c | 26.4 |
Systemic | 0.8 (0.7)a,b | 1.8 (0.8)a,c | 2.5 (0.8)b,c | 62.9 |
Respiratory | 0.6 (0.5)a,b | 1.3 (0.6)a,c | 1.7 (0.6)b,c | 47.7 |
GI | 0.4 (0.4)a,b | 0.8 (0.6)a,c | 1.3 (0.9)b,c | 32.7 |
Senses | 1.2 (1.5)a,b | 1.9 (1.6)a | 2.2 (1.6)b | 5.6 |
Total (not including senses) | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.6)b,c | 74.4 |
Total | 0.6 (0.5)a,b | 1.4 (0.6)a,c | 1.9 (0.5)b,c | 64.1 |
Data are presented as mean (standard deviation) unless otherwise indicated.
Abbreviations: GI, gastrointestinal; ILI, influenza-like illness.
No/mild symptoms compared with moderate symptoms (P<.05).
No/mild symptoms compared with severe symptoms (P<.05).
Moderate symptoms compared with severe symptoms (P<.05).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.